Search results
Results from the WOW.Com Content Network
Thursday, the FDA granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron ...
On Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax 2024-2025 formula, which targets the SARS-CoV-2 variant JN.1. The submission is ...
New Covid boosters approved as CDC set to decide who should receive them amid rising cases Monday 11 September 2023 19:38 , Graeme Massie Health officials say that the Pfizer and Moderna shots ...
The approval was updated in September 2021, to include people aged twelve and older. [14] The Moderna Spikevax COVID-19 vaccine was authorized in Canada in September 2021, for people aged 12 and older. [22] [4] [182] The Moderna Spikevax COVID-19 vaccine was authorized in the US in January 2022, for people aged 18 and older. [1] [38] [41]
An updated Coronavirus booster that targets a new variant is expected to be made available in September
The FDA authorizes the first bivalent COVID-19 booster for ages 5-11. ... CDC approves Pfizer, Moderna's COVID-19 boosters for ages 5 and up. Anjalee Khemlani. October 12, 2022 at 10:24 AM.
In September 2023, the FDA approved an updated monovalent (single) component Omicron variant XBB.1.5 version of the vaccine (Comirnaty 2023–2024 formula) as a single dose for individuals aged twelve years of age and older; [30] and authorized the Pfizer-BioNTech COVID-19 Vaccine 2023–2024 formula under emergency use for individuals aged 6 ...
The Food and Drug Administration authorized Pfizer and Moderna's updated Covid boosters, which target the BA.5 omicron subvariant. FDA authorizes Pfizer's and Moderna's updated Covid booster shots ...